Mobile Health Program for Rural Hypertension
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Pittsburgh
About this trial
Hypertension (HTN) is the leading modifiable cause of cardiovascular disease. Rural individuals experience challenges of the rural health divide: geographic distance from providers, social isolation, limited social resources, and high rates of low health literacy. This study evaluates a home-based blood pressure monitoring (HBPM) program that provides longitudinal health education, empathic guidance, monitoring, and adaptable patient-centered coaching to rural individuals. Participants in this study will be randomized to receive (1) HBPM with the intervention; or (2) the control, consisting of HBPM and a smartphone with a general health application (WebMD).
Eligibility criteria
Qualifiers
History of uncontrolled hypertension, identified from the electronic health record problem list and an average systolic BP 140-199 or diastolic BP 90-119 mm Hg at 2 ambulatory visits, one of which is within 6 months of study entry
Residence in one of 48 counties categorized as rural by the Center for Rural Pennsylvania;
English-speaking at level appropriate for informed consent and study participation;
No plans to relocate from the area within 12 months of enrollment.
Disqualifiers
Heart failure necessitating hospital admission ≤3 months prior to study inclusion;
Acute coronary syndrome (defined as at least 2 of the following: chest pain, ischemic electrocardiographic changes, or troponin ≥0.1 ng/mL) ≤3 months prior to study inclusion;
Planned major surgery, cardiovascular or non-cardiovascular;
Pregnancy or planned pregnancy within 12 months;
Trial design
Treatments tested in this trial
- Coaching application
- WebMD
- Home-based blood pressure monitoring
Treatment groups
334 Participants
are divided into 2 treatment groupsSponsors and collaborators
University of Pittsburgh
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov